Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1979 Jun;37(2):333–338.

Suppression by radioactive strontium of the spontaneous cytotoxicity expressed by adherent, predominantly phagocytic cells from various mouse tissues.

R Keller
PMCID: PMC1457512  PMID: 468306

Abstract

Adherent, predominantly phagocytic effector cells which have previously been shown to occur in a large number of tissues of mice and rats have the spontaneous capacity to kill a variety of syngeneic, allogeneic and xenogeneic target cells in vitro. The present work shows that 89Sr treatment of mice suppressed this spontaneous cytotoxicity, thus indicating that the effector cells pass a substantial part of their life in the bone marrow. In contrast, the capacity to mobilize mononuclear phagocytes and to enhance cytotoxicity in response to an appropriate stimulus were not consistently impaired.

Full text

PDF
333

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander P. The functions of the macrophage in malignant disease. Annu Rev Med. 1976;27:207–224. doi: 10.1146/annurev.me.27.020176.001231. [DOI] [PubMed] [Google Scholar]
  2. Bennett M., Baker E. E., Eastcott J. W., Kumar V., Yonkosky D. Selective elimination of marrow precursors with the bone-seeking isotope 89Sr: implications for hemopoiesis, lymphopoiesis, viral leukemogenesis and infection. J Reticuloendothel Soc. 1976 Jul;20(1):71–87. [PubMed] [Google Scholar]
  3. Bennett M., Baker E. E. Marrow-dependent cell function in early stages of infection with Listeria monocytogenes. Cell Immunol. 1977 Sep;33(1):203–210. doi: 10.1016/0008-8749(77)90147-2. [DOI] [PubMed] [Google Scholar]
  4. Bennett M. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells. J Immunol. 1973 Feb;110(2):510–516. [PubMed] [Google Scholar]
  5. Burnet F. M. The concept of immunological surveillance. Prog Exp Tumor Res. 1970;13:1–27. doi: 10.1159/000386035. [DOI] [PubMed] [Google Scholar]
  6. Fried W., Gurney C. W., Swatek M. The effect of strontium-89 on the stem cell compartment of the spleen. Radiat Res. 1966 Sep;29(1):50–56. [PubMed] [Google Scholar]
  7. Haller O., Wigzell H. Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent. J Immunol. 1977 Apr;118(4):1503–1506. [PubMed] [Google Scholar]
  8. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  9. Keller R. Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages. J Exp Med. 1973 Sep 1;138(3):625–644. doi: 10.1084/jem.138.3.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Keller R. Macrophage-mediated natrual cytotoxicity against various target cells in vitro. I. Macrophages from diverse anatomical sites and different strains of rats and mice. Br J Cancer. 1978 May;37(5):732–741. doi: 10.1038/bjc.1978.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Keller R. Macrophage-mediated natural cytotoxicity against various target cells in vitro. II. Macrophages from rats of different ages. Br J Cancer. 1978 May;37(5):742–746. doi: 10.1038/bjc.1978.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Keller R. Promotion of tumor growth in vivo by antimacrophage agents. J Natl Cancer Inst. 1976 Dec;57(6):1355–1361. doi: 10.1093/jnci/57.6.1355. [DOI] [PubMed] [Google Scholar]
  13. Keller R. Susceptibility of normal and transformed cell lines to cytostatic and cytocidal effects exerted by macrophages. J Natl Cancer Inst. 1976 Feb;56(2):369–374. doi: 10.1093/jnci/56.2.369. [DOI] [PubMed] [Google Scholar]
  14. Kiessling R., Haller O. Natural killer cells in the mouse: an alternative immune surveillance mechanism? Contemp Top Immunobiol. 1978;8:171–201. doi: 10.1007/978-1-4684-0922-2_6. [DOI] [PubMed] [Google Scholar]
  15. Kirchner H., Hirt H. M., Becker H., Munk K. Production of an antiviral factor by murine spleen cells after treatment with Corynebacterium parvum. Cell Immunol. 1977 Jun 1;31(1):172–176. doi: 10.1016/0008-8749(77)90016-8. [DOI] [PubMed] [Google Scholar]
  16. Klein G., Klein E., Haughton G. Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus. J Natl Cancer Inst. 1966 Apr;36(4):607–621. doi: 10.1093/jnci/36.4.607. [DOI] [PubMed] [Google Scholar]
  17. Kumar V., Bennett M., Eckner R. J. Mechanisms of genetic resistance to friend virus leukemia in mice. J Exp Med. 1974 May 1;139(5):1093–1109. doi: 10.1084/jem.139.5.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Levy M. H., Wheelock E. F. The role of macrophages in defense against neoplastic disease. Adv Cancer Res. 1974;20:131–163. doi: 10.1016/s0065-230x(08)60110-4. [DOI] [PubMed] [Google Scholar]
  19. Schwartz R. S. Another look at immunologic surveillance. N Engl J Med. 1975 Jul 24;293(4):181–184. doi: 10.1056/NEJM197507242930406. [DOI] [PubMed] [Google Scholar]
  20. Vasudevan D. M., Brunner K. T., Cerottini J. C. Detection of cytotoxic T lymphocytes in the EL4 mouse leukemia system: increased activity of immune spleen and peritoneal cells following preincubation and cell fractionation procedures. Int J Cancer. 1974 Sep 15;14(3):301–313. doi: 10.1002/ijc.2910140303. [DOI] [PubMed] [Google Scholar]
  21. Volkman A. Disparity in origin of mononuclear phagocyte populations. J Reticuloendothel Soc. 1976 Apr;19(4):249–268. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES